dihexa cognitive enhancement 2019 chemically induced 2024 aged Alzheimer's disease drug development pipeline: - Cummings - 2024 - Alzheimer's & Dementia: Translational Research & Clinical Interventions 10-K
10 K Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease DIHEXA Beverly Hills Rejuvenation Center Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive Antidementia Agents PMC AngIV Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP PS1 Mouse via the PI3K AKT Signaling Pathway PMC
Pay in 4 interest-free payments of $5.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




